ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 97 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.84 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $174,854 | +402.2% | 55,159 | +687.3% | 0.00% | – |
| Q2 2023 | $34,820 | -33.6% | 7,006 | -34.0% | 0.00% | – |
| Q1 2023 | $52,423 | +2793.1% | 10,612 | +3584.7% | 0.00% | – |
| Q4 2022 | $1,812 | -99.0% | 288 | -97.7% | 0.00% | – |
| Q4 2021 | $186,000 | +132.5% | 12,460 | +299.9% | 0.00% | – |
| Q3 2021 | $80,000 | -32.8% | 3,116 | -31.5% | 0.00% | – |
| Q2 2021 | $119,000 | -82.9% | 4,550 | -77.0% | 0.00% | -100.0% |
| Q1 2021 | $697,000 | +2930.4% | 19,743 | +2062.4% | 0.00% | – |
| Q4 2020 | $23,000 | -85.3% | 913 | -84.8% | 0.00% | -100.0% |
| Q4 2019 | $156,000 | +721.1% | 6,005 | +751.8% | 0.00% | – |
| Q3 2019 | $19,000 | -5.0% | 705 | -4.7% | 0.00% | – |
| Q2 2019 | $20,000 | +185.7% | 740 | +208.3% | 0.00% | – |
| Q1 2019 | $7,000 | – | 240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |